Pharma
Despite FDA crackdown, unapproved GLP-1s still threaten the industry
Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn.
FDA Approvals
Stay updated on FDA Approvals trends and industry impact. Healthcare Brew provides the latest news and professional analysis on FDA Approvals's role in Regulations & Drug Approval and Pharma.
Pharma
Could relaxed regulations boost gene therapy for ultra-rare diseases?
Companies like Prime Medicine and Aurora Therapeutics are shooting their shot.
Pharma
What new advertising rules may mean for pharma companies
The Trump administration’s crackdown on direct-to-consumer pharma ads could make TV advertising “very expensive and very difficult,” one expert said.
Pharma
Sarepta to cut 36% of staff, add black-box warning to Elevidys
The layoffs come after two deaths of patients who had taken its most profitable product, Elevidys.
Pharma
Pharma tariffs are coming ‘very shortly.’ Here’s how they could impact healthcare
Companies are likely to see cost increases despite an initial exemption.
Pharma
Lawmakers, health experts call on FDA to pull Hims & Hers Super Bowl ad
Advocacy group and bipartisan letters urged the FDA to take action and pull the ad from running during Sunday’s game.
Pharma
Lykos CEO steps down following FDA rejection of MDMA therapy
The move comes after the company laid off 75% of its staff.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
